{"schema_version":"secwatch.filing_event.v1","accession":"0000310764-24-000005","form_type":"8-K","ticker":"SYK","cik":"0000310764","company_name":"STRYKER CORP","filed_at":"2024-01-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.534536+00:00","generated_at":"2026-06-06T15:19:06.693125+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Stryker Q4 organic sales up 11.4%; FY23 revenue $20.5B; guides FY24 adj EPS $11.70-$12.00","bullets":["Q4 organic net sales growth 11.4% to $5.8B; full year organic growth 11.5% to $20.5B.","Q4 adjusted EPS $3.46 (+15.3% YoY); full year adjusted EPS $10.60 (+13.5%).","Adjusted operating margin expanded 60 bps in Q4 to 27.2%; full year 24.2% (+40 bps).","MedSurg & Neuro organic sales up 11.8% in Q4 and full year; Ortho & Spine up 10.7% Q4, 11.1% FY.","FY2024 outlook: organic sales growth 7.5%-9.0%; adjusted EPS $11.70-$12.00."],"urls":{"canonical":"https://secwatch.observer/filing/0000310764-24-000005","json":"https://secwatch.observer/filing/0000310764-24-000005.json","markdown":"https://secwatch.observer/filing/0000310764-24-000005.md","text":"https://secwatch.observer/filing/0000310764-24-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310764/000031076424000005/0000310764-24-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310764/000031076424000005/syk-20240130.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T15:19:06.693125+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8f94cb22b0b783eedc453a5357ebe750615635d3","claim":"STRYKER CORP updated its the fourth quarter and full year of 2023 guidance (reaffirmed).","evidence_excerpt":"Stryker Corporation issued a press release on January 30, 2024 announcing its fourth quarter and full-year 2023 operating results and 2024 outlook.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/310764/000031076424000005/0000310764-24-000005-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and full year of 2023"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}